Toripalimab Evidence Journey in Cancer Care

By Rene Pretorius

April 9, 2025

The FDA approved toripalimab (Loqtorzi) on October 27, 2023, as the first immunot...
HPV Testing in Head and Neck Squamous Cell Carcinoma
Prior Authorization Elimination: Is Optum Rx moving towards Access Efficiency?
Advancing Heart Transplantation: The Role of the Lumped Parameter Model
Molecular Insights into Angiogenesis in Colorectal Cancer
Journavx Market Access Strategy in Focus: What Early Payer Decisions Signal f...
NovoCare and the Rise of Direct-to-Consumer Pharmaceutical Access
Global Childhood Cancer Access
New Global AIDS Strategy 2030 Aims to End AIDS Threat by 2030
Lenacapavir HIV Prevention: Approval and Access Strategy Updates
Genetic Testing in South Africa
PEPFAR Funding Pause Threatens Global HIV Progress
Healthcare at Home: CMC Dubai’s Innovative Program